Clinical implication of plasma natriuretic peptides in children with ventricular septal defect

Pediatrics International

Volumn 45, Issue 3, 2003, Pages 249-254

  Suda, Kenji ^a   Matsumura, Masahiko ^a   Matsumoto, Masahiko ^a  

^a TENRI HOSPITAL   (Japan)

Author keywords

A type natriuretic peptide; B type natriuretic peptide; Pulmonary artery pressure; Ventricular septal defect

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE;

ADOLESCENT; ARTICLE; CHILD; CORRELATION ANALYSIS; FEMALE; HEART CATHETERIZATION; HEART RIGHT VENTRICLE PRESSURE; HEART VENTRICLE SEPTUM DEFECT; HEART VENTRICLE VOLUME; HEMODYNAMICS; HORMONE BLOOD LEVEL; HUMAN; IMMUNORADIOMETRIC ASSAY; INFANT; LUNG ARTERY PRESSURE; LUNG BLOOD FLOW; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; SENSITIVITY AND SPECIFICITY; SYSTEMIC CIRCULATION;

ADOLESCENT; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; CHILD; CHILD, PRESCHOOL; FEMALE; HEART FAILURE, CONGESTIVE; HEART SEPTAL DEFECTS, VENTRICULAR; HEMODYNAMIC PROCESSES; HUMANS; INFANT; MALE; NATRIURETIC PEPTIDE, BRAIN; PULMONARY CIRCULATION; VASCULAR RESISTANCE;

EID: 0042163118     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-200X.2003.01716.x     Document Type: Article

References (24)

1. Bates ER, Shenker Y, Grekin RJ. The relationship between plasma levels of immunoreactive atrial natriuretic hormone and hemodynamic function in man. Circulation 1986; 73: 1155-61.
2. Raine AGE, Erne P, Burgisser E et al. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N. Engl. J. Med. 1986; 315: 533-7.
3. Weil J, Bidlingmaier F, Dohlemann C et al. Comparison of plasma atrial natriumtic peptide levels in healthy children from birth to adolescence and in children with cardiac disease. Pediatr. Res. 1986; 20: 1328-31.
4. Matsuoka S, Kurahashi Y, Tomimatsu H et al. Plasma atrial natriuretic peptide levels in patients with ventricular septal defect. J. Pediatr. 1987; 110: 578-80.
5. Kikuchi K, Nishioka K, Ueda T et al. Relationship between plasma atrial natriuretic peptide concentration and hemodynamic measurements in children with congenital heart diseases. J. Pediatr. 1987; 111: 335-42.
6. Andersson S, Tikkanen I, Pesonen E, Meretoja O, Hynynen M, Fyhrquist F. Atrial natriuretic peptide in patent ductus arteriosus. Pediatr. Res. 1987; 21: 396-8.
7. Oberhansli I, Mermillod B, Favre H, Friedli B, Girardin E, Paunier L. Atrial natriuretic factor in patients with congenital heart disease: correlation with hemodynamic variables. J. Am. Coll. Cardiol. 1990; 15: 1438-45.
8. Adnot S, Chabrier PE, Andrivet P et al. Atrial natriuretic peptide concentrations and pulmonary hemodynamics in patients with pulmonary artery hypertension. Am. Rev. Respir. Dis. 1987; 136: 951-6.
9. Tunaoglu FS, Olgunturk FR, Gokcora N, Turkyilmaz C, Gurbuz F. Atrial natriuretic peptide concentrations in children with pulmonary hypertension: correlation with hemodynamic measurements. Pediatr. Cardiol. 1994; 15: 288-95.
10. Yasue H, Yoshimura M, Sumida H et al. Localization and mechanism of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994; 90: 195-203.
11. Nakagawa O, Ogawa Y, Itoh H et al. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an 'emergency' cardiac hormone against ventricular overload. J. Clin. Invest. 1995; 96: 1280-87.
12. Nishikimi T, Yoshihara F, Morimoto A et al. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 1996; 28: 22-30.
13. Nagaya N, Nishikimi T, Uematsu M et al. Secretion patterns of brain natriuretic peptide and atrial natriuretic peptide in patients with or without pulmonary hypertension complicating atrial septal defect. Am. Heart J. 1998; 136: 297-301.
14. Mair J, Friedl W, Thomas S, Puschendorf B. Natriuretic peptides in assessment of left-ventricular dysfunction. Scand. J. Clin. Lab. Invest. Suppl. 1999; 59: 132-42.
15. Richards AM, Nicholls MG, Yandle TG et al. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. Heart 1999; 81: 114-20.
16. Cheng V, Kazanagra R, Garcia A et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J. Am. Coll. Cardiol. 2001; 37: 386-91.
17. Nagaya N, Nishikimi T, Okano Y et al. Plasama brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J. Am. Coll. Cardiol. 1998; 31: 202-8.
18. Nagaya N, Nishikimi T, Uematus M et al. Plasma brain natriuretic peptide as a prognositc indicator in patients with primary pulmonary hypertension. Circulation 2000; 102: 865-70.
19. Cargill RI, Lipworth BJ. Pulmonary vasorelaxant activity of atrial natriuretic peptide and brain natriuretic peptide in humans. Thorax 1995; 50: 183-5.
20. Cargill RI, Lipworth BJ. The role of the renin-angiotensin and natriuretic peptide systems in the pulmonary vasculature. Br. J. Clin. Pharmacol. 1995; 40: 11-18.
21. Itoh H, Pratt RE, Dzau VJ. Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. J. Clin. Invest. 1990; 86: 1690-97.
22. Vasan RS, Levy D, Larson MG, Benjamin EJ. Interpretation of echocardiographic measurements: a call for standardization. Am. Heart J. 2000; 139: 412-22.
23. Sabry AF, Reller MD, Silberbach M, Rice MJ, Sahn DJ. Comparison of four Doppler echocardiographic methods for calculating pulmonary-to-systemic shunt flow ratios in patients with ventricular septal defect. Am. J. Cardiol. 1995; 75: 611-14.
24. Liberman L, Kaufman S, Alfayyadh M, Hordof AJ, Apfel HD. Noninvasive prediction of pulmonary artery pressure in patients with isolated ventricular septal defect. Pediatr. Cardiol. 2000; 21: 197-201.